Biotechnology (115) | Development Agreements (115)
Browse by Company
-
Altimmune, Inc. (2)
-
Anixa Biosciences Inc (1)
-
Apellis Pharmaceuticals, Inc. (2)
-
Arcturus Therapeutics Holdings Inc. (4)
-
Atara Biotherapeutics, Inc. (4)
-
Athenex, Inc. (1)
-
BIOCRYST PHARMACEUTICALS INC (12)
-
CASI Pharmaceuticals, Inc. (3)
-
CHIMERIX INC (13)
-
CONTRAFECT Corp (1)
-
Corvus Pharmaceuticals, Inc. (1)
-
Cyclerion Therapeutics, Inc. (1)
-
DiaMedica Therapeutics Inc. (1)
-
Emerald Bioscience, Inc. (2)
-
Emergent BioSolutions Inc. (13)
-
Entasis Therapeutics Holdings Inc. (1)
-
Evelo Biosciences, Inc. (1)
-
Exelixis (1)
-
FIBROGEN INC (1)
-
FS Development Corp. (5)
-
Harpoon Therapeutics, Inc. (3)
-
HUMANIGEN, INC (1)
-
iBio, Inc. (2)
-
Intec Pharma Ltd. (1)
-
Ligand Pharmaceuticals Incorporated (1)
-
Matinas BioPharma Holdings, Inc. (1)
-
Moderna, Inc. (3)
-
NORTHWEST BIOTHERAPEUTICS INC (1)
-
Orchard Therapeutics plc (1)
-
Passage BIO, Inc. (1)
-
Regeneron Pharmaceuticals (1)
-
Revolution Medicines, Inc. (1)
-
RHYTHM PHARMACEUTICALS, INC. (2)
-
SEATTLE GENETICS INC (3)
-
SOPHIRIS BIO INC. (1)
-
T2 Biosystems, Inc. (3)
-
Tracon Pharmaceuticals, Inc. (1)
-
TREVENA INC (1)
-
Vaxcyte, Inc. (3)
-
VERACYTE, INC. (1)
-
Vertex Pharmaceuticals Inc (1)
-
Viela Bio, Inc. (1)
-
Vir Biotechnology, Inc. (1)
-
XOMA Corp (1)
-
ZIOPHARM ONCOLOGY INC (9)
Recent Contracts
-
Amendment of Solicitation/Modification of Contract, dated as of April 30, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S....
(T2 Biosystems, Inc., Filed With SEC on May 13, 2021)
-
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended
(Vaxcyte, Inc., Filed With SEC on May 11, 2021)
-
Amendment No. 7, dated March 12, 2021, to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as...
(Moderna, Inc., Filed With SEC on May 6, 2021)
-
Modification No. 4, effective January 29, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and...
(Emergent BioSolutions Inc., Filed With SEC on April 30, 2021)
-
Therapeutic Development Award Agreement, dated November 19, 2020, between Matinas BioPharma Holdings, Inc. and the Cystic Fibrosis Foundation
(Matinas BioPharma Holdings, Inc., Filed With SEC on March 29, 2021)
-
Cost-Sharing Agreement by and between ContraFect Corporation and the BioMedical Advanced Research and Development Authority, dated March 10, 2021
(CONTRAFECT Corp, Filed With SEC on March 12, 2021)
-
Joint Development and Option Agreement, dated January 26, 2021, between the Company and The Cleveland Clinic Foundation. (Certain information has been redacted in the marked...
(Anixa Biosciences Inc, Filed With SEC on March 11, 2021)
-
Amended and Restated Cooperative Research and Development Agreement, dated as of January 21, 2021, by and among the Registrant, Joint Program Executive Office for Chemical,...
(HUMANIGEN, INC, Filed With SEC on March 10, 2021)
-
Development and Clinical Master Services Agreement between Evelo Biosciences, Inc. and Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany dated December 17, 2020
(Evelo Biosciences, Inc., Filed With SEC on March 9, 2021)
-
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
(BIOCRYST PHARMACEUTICALS INC, Filed With SEC on March 1, 2021)
